Locations:

Tag: vamsidhar velcheti

July 9, 2018/Cancer/Research

ALT-803 + Nivolumab Found Safe, Effective in Metastatic NSCLC

An IL-15 superagonist shows promise

June 5, 2018/Cancer/Research

Higher Blood-Based Tumor Burden Predicts Better Response to Immunotherapy in Metastatic NSCLC Patients

Results based on early data from clinical trial

March 7, 2018/Cancer/Innovations

New Imaging Technology May Help Predict Aggressiveness of Lung Cancer

Research supported by a recent $3.16 million NCI grant

September 25, 2017/Cancer/Research

Novel, Targeted Therapies for Patients with Advanced, RET-Positive NSCLC

Lenvatinib promising, trials ongoing

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next